EUVIMEDEUVIMED entdecken
Crossref

A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?

Katie Watson

New England Journal of Medicine · 2024

DOI: 10.1056/nejmms2312012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Katie Watson. Beteiligte Einrichtung: From the Feinberg School of Medicine, Northwestern University, Chicago. Hauptthemen laut MEDLINE: Abortion, Induced, Mifepristone, Supreme Court Decisions, Abortifacient Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, InducedMifepristoneSupreme Court DecisionsAbortifacient AgentsUnited States Food and Drug AdministrationFemaleHumansPregnancyUnited States

Substanzen

MifepristoneAbortifacient Agents

Autor:innen und Institutionen

  • From the Feinberg School of Medicine, Northwestern University, Chicago.

Zitieren

APA

Watson, K. (2024). A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?. New England Journal of Medicine. https://doi.org/10.1056/nejmms2312012

Vancouver

Watson K. A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?. New England Journal of Medicine. 2024. doi:10.1056/nejmms2312012

BibTeX
@article{Watson2024,
  author = {Watson, Katie},
  title = {A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmms2312012}
}
Kostenlos starten →